Clicky

Stoke Therapeutics, Inc.(STOK) News

Date Title
Jan 11 Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results
Jan 8 Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
Jan 4 Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Jan 2 Why healthcare, biotech may be top plays for 2024: BTIG
Dec 1 Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society (AES) 2023 Annual Meeting
Sep 5 Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress
Jun 21 Stoke Therapeutics, Inc. (STOK) Surges 6.3%: Is This an Indication of Further Gains?